Patents/Inventors

Yongxin Han

Needham, MAUS12 patents

13 Patents

US125760872026
Aryloxypiperidine Pyrazole Compounds as Indoleamine 2,3-dioxygenase Inhibitors
Merck Sharp & Dohme LLC
0 cites
US122972082025
Small Molecule Inhibitors of KRAS G12C Mutant
Merck Sharp & Dohme LLC
0 cites
US122915382025
Small Molecule Inhibitors of KRAS G12C Mutant
Merck Sharp & Dohme LLC
0 cites
US122757292025
Substituted Tetrahydroquinolin Compounds as Indoleamine 2,3-dioxygenase (IDO) Inhibitors
Merck Sharp & Dohme LLC
0 cites
US122641342025
Substituted Piperazine Amide Compounds as Indoleamine 2,3-dioxygenase (IDO) Inhibitors
Merck Sharp & Dohme LLC
0 cites
US122641392025
Aryl Sulfonamides as BLT1 Antagonists
Merck Sharp & Dohme LLC
0 cites
US121577272024
Substituted Tetrahydroquinolin Compounds as Indoleamine 2,3-dioxygenase (IDO) Inhibitors
Merck Sharp & Dohme LLC
0 cites
US121520192024
Arylalkyl Pyrazole Compounds as Indoleamine 2,3-dioxygenase Inhibitors
Merck Sharp & Dohme LLC
0 cites
US120914052024
Substituted Pyrazole Compounds as Indoleamine 2,3-dioxygenase Inhibitors
Merck Sharp & Dohme LLC
0 cites
US120654382024
Substituted Tricyclic Compounds as Indoleamine 2,3-dioxygenase Inhibitors
Merck Sharp & Dohme LLC
0 cites
US119924892024
Substituted Tetrahydroquinoline Compounds as Indoleamine 2,3-dioxygenase Inhibitors
Merck Sharp & Dohme LLC
0 cites
US116976572023
Small Molecule Inhibitors of KRAS G12C Mutant
Merck Sharp & Dohme LLC
0 cites
US116552162023
Aryl and Heteroaryl Ether Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their Use
Merck Sharp & Dohme LLC
0 cites